...
首页> 外文期刊>Annals of Surgery >Emergency subtotal hepatectomy: a new concept for acetaminophen-induced acute liver failure: temporary hepatic support by auxiliary orthotopic liver transplantation enables long-term success.
【24h】

Emergency subtotal hepatectomy: a new concept for acetaminophen-induced acute liver failure: temporary hepatic support by auxiliary orthotopic liver transplantation enables long-term success.

机译:紧急次全肝切除术:对乙酰氨基酚引起的急性肝衰竭的新概念:通过辅助原位肝移植获得临时肝支持可取得长期成功。

获取原文
获取原文并翻译 | 示例
           

摘要

INTRODUCTION: Acetaminophen (paracetamol) overdose (AOD) has recently emerged as the leading cause of acute liver failure (ALF) in the United States, with an incidence approaching that seen in the United Kingdom. We describe a new way to treat AOD ALF patients fulfilling King's College criteria for "super-urgent" liver transplantation. METHODS: Beginning in June 1998, we have been piloting a clinical program of subtotal hepatectomy and auxiliary orthotopic liver transplantation (ALT) for AOD ALF. Our technique is based on the following principles: (1) subtotal hepatectomy; (2) auxiliary transplantation of a whole liver graft; (3) gradual withdrawal of immunosuppression after recovery. Results were compared with patients who had undergone an orthotopic liver transplantation (OLT) for AOD ALF in the same period. Quality of life comparisons were made using the SF36 questionnaire. RESULTS: Thirteen patients underwent this procedure between June 1998 and March 2005. Median survival is 68 months (range, 0-102 m). Actual survival data show that 9 of 13 patients are alive (69%) compared with 7 of 13 OLT patients (54%). One ALT patient required a retransplantation with an OLT due to hepatic vein thrombosis, and immunosuppression is therefore maintained. The other 8 surviving ALT patients are off immunosuppression. These 8 ALT patients have normal liver function and have a better quality of life compared with the 7 surviving OLT patients. CONCLUSION: Our results with this new technique are encouraging: 69% actual survival, no long-term immunosuppression requirement, and improved quality of life in the 62% successful cases.
机译:简介:对乙酰氨基酚(对乙酰氨基酚)过量(AOD)最近在美国成为急性肝衰竭(ALF)的主要原因,其发病率已接近英国。我们描述了一种新的治疗AOD ALF患者的新方法,该患者符合King's College的“超紧急”肝移植标准。方法:从1998年6月开始,我们一直在试行AOD ALF的次全肝切除术和辅助原位肝移植(ALT)的临床计划。我们的技术基于以下原则:(1)肝大部切除术; (2)全肝移植的辅助移植; (3)恢复后逐渐停止免疫抑制。将结果与同期接受原位肝移植(OLT)的AOD ALF患者进行比较。使用SF36问卷进行生活质量比较。结果:1998年6月至2005年3月,共有13例患者接受了该手术。中位生存期为68个月(范围为0-102 m)。实际生存数据显示13例患者中有9例活着(69%),而13例OLT患者中有7例(54%)存活。一名ALT患者由于肝静脉血栓形成而需要重新移植OLT,因此维持了免疫抑制。其余8名存活的ALT患者均未进行免疫抑制。与7例存活的OLT患者相比,这8例ALT患者的肝功能正常,生活质量更高。结论:这项新技术的结果令人鼓舞:62%成功病例的实际存活率为69%,无长期免疫抑制要求,生活质量得到改善。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号